The first animal model for APS‐1 was engineered in 2002; these Aire−/− mice exhibited lymphocytic infiltration and circulating serum autoantibodies against specific structures of targeted organs.18, 27. This evidence concerns the gene AIRE and autoimmune polyendocrine syndrome type 1.